ATLANTA, GA – – (Globe Newswire – May 1, 2024) – – Holzer & Holzer, LLC is investigating whether CVRx, Inc. (“CVRx” or the “Company”) (NASDAQ: CVRX) complied with federal securities laws. On April 30, 2024, CVRx announced its financial and operating results for the first quarter of 2024, noting the “lower than anticipated revenue was due primarily to the performance of our U.S. Heart Failure business, where there was some disruption within our sales organization at the time of the CEO transition, which led to decreased productivity and some sales force turnover.” Following this news, the price of the Company’s stock dropped.

If you purchased CVRx stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share